How individualized medicine might be approved with existing regulations
Dr. Eric Hoffman envisions that some parts of the approval process may be developed for DNA-like molecular medicine as a ‘class’ of drugs, rather than individual testing of hundreds of different sequences. Dr. Hoffman is a world-renowned human geneticist, who is the Director of the Research Center for Genetic Medicine, a James Clark Professor of …